The American Society of Echocardiography - Scientific Sessions

Echocardiography: At the cutting edge of science and medicine

Click to visit ASE's Connect profile
Click to visit ASE's Facebook profile
Click to visit ASE's X profile
Click to visit ASE's LinkedIn profile
Click to visit ASE's Youtube
Click to visit ASE's Instagram
  • Registration
    • Course Cancellation Policy
  • Education
    • ASE 2025 Program Details
    • DIY Workshops
    • CME Information
    • 2025 Program Committee
  • Call for Science
    • Guidelines for Abstract Preparation and Submission
    • Investigator Award Competitions
    • FAQs
  • Exhibits & Sponsors
    • ASE 2025 Exhibitors
    • Exhibitor Information
    • Science & Technology Theaters
    • Satellite Symposia
    • Industry Round Table Partners
  • For Attendees
    • Housing
    • Code of Conduct for ASE Courses
    • Future Dates
  • Special Events
    • Science & Technology Theaters
    • Award Winners
    • ASE 2025 Shark Tank Innovation Competition
    • Satellite Symposia
  • Help
    • FAQs
    • Contact us
You are here: Home / Science & Technology Theaters

Science & Technology Theaters

These sessions are not part of the official ASE 2025 Scientific Sessions as planned by the Program Committee or in any way endorsed by or affiliated with ASE.


Friday, September 5


1:30– 2:30 PM
THEATER 2

Seeing the Signs: Mastering the Echo-Based Diagnosis of Obstructive Hypertrophic Cardiomyopathy (oHCM)

Objectives

  • Demonstrate different diagnostic tools and techniques, including Valsalva, used to identify oHCM through detailed case studies
  • Recognize clinical clues that may indicate the need for further assessment of oHCM, in conjunction with recommendations by a healthcare provider
  • Provide comprehensive information on specific imaging options and interpreting diagnostic images for effectively diagnosing oHCM

Presented by Cytokinetics

Cytokinetics Color Logo


Saturday, September 6


12:30 – 1:30 PM
THEATER 1

Enhancing Cardiac Imaging: The Role of a UEA in Cardiomyopathy Assessment

This symposium explores the pivotal role of ultrasound enhancing agents (UEAs) in echocardiographic assessment of cardiomyopathies. By enhancing image clarity, a UEA facilitates more accurate evaluations of left ventricle endocardial borders, which is crucial in diagnosing and managing cardiomyopathies.

Speaker: Kristen Billick, ACS, RCS, RDCS, FASE

Presented by Lantheus


12:30– 1:30 PM
THEATER 2

AI that works: Validated Efficiency in Cardiac Ultrasound

Join us for lunch to hear the results of the ASE AI Validation Study, a randomized study validating AI in cardiac ultrasound. Discover how AI-powered tools on the ACUSON Origin ultrasound system significantly reduced exam time and ergonomic movement while delivering consistent, reliable measurements with minimal need for manual edits.

ASE AI Validation Study overview:  Lissa Sugeng, MD, MPH, FASE
Key takeaways from the study: Neil J. Weissman, MD, FASE
Why AI matters in the echo lab: Steven Walling, ACS, FASE
AI in strain imaging with and without CEU: Jeffrey Hill, ACS, FASE

Presented by Siemens Healthineers


3:45– 4:45 PM
THEATER 1

The Impact of CAMZYOS (mavacamten) on Cardiac Structure and Function

Speaker: Dermot M. Phelan, MD, PhD, FASE

Presented by Bristol Myers Squibb


Sunday, September 7


12:30– 1:30 PM
THEATER 1

Presented by GE HealthCare


12:30 – 1:30 PM
THEATER 2

Real-World AI for HFpEF & Amyloidosis: Unlocking Diagnostic Power from a Single Echo View

Discover groundbreaking clinical data on the use of AI to advance the detection of HFpEF and Cardiac Amyloidosis. Hear expert insights from Mayo Clinic, The University of Chicago Medicine, and City of Hope. This session shares real-world case studies, customer implementations, and results from the 2025 landmark trial of the first FDA-cleared AI echo-based screening tool for Cardiac Amyloidosis.

Ross Upton, PhD, Founder, CEO & Chief Scientific Officer, Ultromics
Co-Chair, HeartShare AI Committee, NIH

Patricia A. Pellikka, MD, FASE, President, Mayo Clinic Officers and Councilors
Betty Knight Scripps Professor of Cardiovascular Diseases
Editor-in-Chief, JASE

Jeremy A. Slivnick, MD, FASE
Assistant Professor, The University of Chicago Medicine

Faizi A. Jamal, MD, FACC
Chief, Division of Cardiology; Director, Non-Invasive Cardiology Laboratory; Associate Clinical Professor, Department of Medicine, City of Hope

Presented by Ultromics


Quick Links

  • Schedule at a Glance
  • ASE 2025 Program Details
  • Registration
  • Housing
  • ASE Home
  • ASE 2025 Faculty
  • ASE Home
  • Buy Educational Products
  • Connect@ASE
  • Foundation
  • For Patients
  • 2025 Program Committee
  • 2025 Call for Late-Breaking Science
  • ASE Home
  • Contact us
  • Exhibitor Information
  • Future Dates
  • Industry Round Table Partners
  • Privacy Policy

Copyright © 2025 · Outreach Pro Theme on Genesis Framework · WordPress · Log in